Arkansas Supreme Court overturns $1.2B verdict against Johnson & Johnson over Risperdal

Published



McDaniel


LITTLE ROCK, Ark. (Legal Newsline) – The Arkansas Supreme Court has joined its neighbor in reversing a massive verdict against Johnson & Johnson over the prescription drug Risperdal.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.